The Barcelona Institute for Global Health (ISGlobal) is a cutting-edge institute addressing global public health challenges through research, translation into policy and education. ISGlobal has a broad portfolio in communicable and non-communicable diseases including environmental and climate determinants, and applies a multidisciplinary scientific approach ranging from the molecular to the population level. Research is organized in five programs: Climate, Air Pollution, Nature and Urban Health; Environment and Health over the Lifecourse; Global Viral and Bacterial Infections; Malaria and Neglected Parasitic Diseases and Maternal Child and Reproductive Health. ISGlobal is accredited with the Severo Ochoa distinction, a seal of excellence of the Spanish Science Ministry.
ISGlobal is seeking a highly experienced and motivaded Project Manager to join the International Health group and the 3SI-control project. The ideal candidate will have a strong background in clinical trials and demonstrated experience managing complex, multicentre, and international research projects.
Control of soil transmitted helminths (STH) and Schistosomiasis (SCH) has been part of routine programmes for many years, yet, the efficacy and effectiveness of these programmes is challenged by low and failing drug efficacy and growing concerns of anthelmintic resistance, calling for a revision of the MDA-drug strategies. In this regard, the novel fixed-dose co-formulation (FDC) including albendazole and ivermectin has proven to be safe and to overcome most of the challenges in drug efficacy for STH. For T. solium the situation is very different from STH and SCH as currently there are no countries routinely implementing control. 3SI-CONTROL will assess the safety and cost-effectiveness of the FDC co-administration with praziquantel in reducing the prevalence of T. solium, STH and SCH, in a randomised controlled trial embedded in solid implementation research. Results from 3SI-CONTROL will thereby provide a scientific evidence base on the safety and effectiveness of integration of T. solium control with STH and SCH, considering the One Health approach. Beyond this, the substantial implementation research component will enable bridging the gap between the evidence-based practice (results on safety and effectiveness) and the actual implementation in the routine, real-world setting. These results, joined by a comprehensive dissemination and advocacy plan, will provide leverage to stimulate uptake of T. solium in the existing routine NTD control programmes, enabling the implementation of a safe and integrated control strategy with a higher effectiveness, tackling three top ranking NTDs. By harnessing advanced concepts in One Health, implementation research, and pharmacovigilance, our project aims to deliver transformative impacts in NTD control, reducing the individual, social and economic burdens of resource poor rural populations.
Development of study documents and procedures (informed consent form, monitoring plan, manual of procedures, etc) according to the institutional procedures
Participate in the revision/preparation of the trial communication material (leaflets, webpage, updates to stakeholders, etc)
Ensure timely and quality implementation of the project and achievement of the established project objectives
Oversee the contracts and budgets including appropriate allocation
Coordinate reporting of activities and finances
Ensure adequate communication amongst the partners in the consortium
Ensure the project is executed within the allocated budget and timeline
Support for grant applications
Provide support to the clinical trial team on trial activities (essential record management, data management, site coordination, etc)
Responsible for the daily functioning and coordination with ISGlobal internal departments (financial and legal department, travel agency, etc)
Development of study documents, plans and procedures
Informed consent/assent development
Assure appropriate and timely allocation of resources necessary to achieve objectives
Prepare contingency plans/decision trees and reports
Participation in meetings
Preparation of technical reports and ensure on-time submission
Monitor contractual agreements
Preparation and coordination of conference calls and meetings
Agenda and minutes writing
Follow up on agreed actions
Oversee budget management and procurement
Regular follow up of budget with the financial manager at ISGlobal
Follow up with partners on implementation of actions and budget
Support the trial management activities
AUXILIAR TASKS
This job description reflects the present requirements of the post but may evolve at any time in the future as duties and responsibilities change and/or develop providing there is appropriate consultation with the post-holder.
This job description is not a definitive or exhaustive list of responsibilities but identifies the key responsibilities and tasks of the post holder. The specific objectives of the post holder will be subject to review as part of the individual professional assessment process.
Proactive
Excellent management, project planning, and organizational skills
Problem solving skills
Ability to effectively work both as a team member and independently
The post holder will adhere to ISGlobal principles contained in People management policy, including Equity, diversity and health safety. The post holder will respect, and be accountable to ensure ISGlobal policies and procedures.
University degree in health sciences
At least 2 years of project management experience in health or related field
A PhD in health sciences is a strong plus
Current ICH/GCP certification
Excellent computer skills: MS Word, Excel, PowerPoint or equivalent
Experience working in international and multi-cultural environment
Experience in clinical trials in LMIC is a strong plus
Contract: 3 years, full time
Salary: According to ISGlobal internal salary scale
Work-Life Balance: 36 days off per year (23 vacation days + 13 personal days)
Start date: August 2027
Applicants must complete the application form and upload a CV and a Cover Letter. Each document must be clearly named with the candidate’s name and surname.
Applications will remain open until 6th of July.
Applications will be reviewed on a rolling basis, and shortlisted candidates may be contacted and interviewed as applications are received. Interviews may take place during the application period.
We encourage diverse applications, including but not limited to gender, race, ethnicity, religion, age, sexual orientation, physical abilities, and political beliefs.
The selection process is designed in two phases:
1- Interview phase of a technical nature, with the team that requires the incorporation. To assess the person's skills and CV.
2 - Meeting with HR with the finalist(s) to finish assessing the profile and discuss contractual and institutional issues.
If needed any technical test could be passed. A Psychological Competency Evaluation Test will be required for the structural or transversal positions.
In accordance with the OTM-R principles, a gender-balanced recruitment panel is formed for every vacancy at the beginning of the process. After reviewing the content of the applications, the panel will start the interviews, with at least one technical and one administrative interview. A profile questionnaire as well as a technical exercise may be required during the process.
In ISGlobal we are committed to maintaining and developing a work environment in which the values and principles of our organization are respected and equal opportunities between women and men be promoted in each of the areas in which we operate, not tolerating discrimination based on criteria such as age, gender, marital status, race, ethnicity, functional diversity, political leanings, religion, sexual orientation, gender identity or gender expression.
We confirm our commitment towards the value of the diversity of our staff and student population and seek to promote peace, equity, diversity and inclusion as essential elements in contribution to improving health worldwide.
